Preclinical safety assessment: In vitro - in vivo testing

Pharmacology and Toxicology, Supplement

Volumn 86, Issue 1, 2000, Pages 6-7

  Højelse, Flemming ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DRUG MARKETING; DRUG SCREENING; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; TOXICITY TESTING;

EID: 0033922324     PISSN: 09019936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.d01-2.x     Document Type: Conference Paper

References (2)

1. Brown, N. A., H. Spielman, R. Bechter et al.: Screening chemicals for reproductive toxicity, the current alternatives. The report and recommendations of an ECVAM/ETS workshop (ECVAM workshop 12). ATLA 1995, 23, 868-882.
2. ICH Harmonised Tripartite Guideline, CPMP Guideline for - Carcinogenicity studies of pharmaceuticals (CPMP/ICH(141/95) - Genotoxicity tests for pharmaceuticals (CPMP/TCH/141/95) - Detection of toxicity to reproduction for medicinal products (CPMP/SWP/386/95) - Note for guidance on safety pharmacology studies in medicinal product development (draft from 13 May, 1998) (CPMP/SWP/ 872/98).